DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > School of Medicine > Articles in academic journal >

Blockade of IL-2 Receptor Suppresses HTLV-I and IFN-ホウ Expression in Patients with HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis


File Description SizeFormat
IM_46_7_347.pdf377.41 kBAdobe PDFView/Open

Title: Blockade of IL-2 Receptor Suppresses HTLV-I and IFN-ホウ Expression in Patients with HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis
Authors: Fukushima, Naomi / Nishiura, Yoshihiro / Nakamura, Tatsufumi / Kohno, Shigeru / Eguchi, Katsumi
Issue Date: Apr-2007
Publisher: 日本内科学会 / The Japanese Society of Internal Medicine
Citation: Internal Medicine, vol.46(7), pp.347-351; 2007
Abstract: Objective: Th1 activation based on a high HTLV-I proviral load is one of the characteristic immunological abnormalities in the peripheral blood lymphocytes of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). To clarify the cause of this abnormality with the potential to be one of the therapeutic targets, we analyzed the involvement of interleukin-2 (IL-2)/IL-2 receptor (IL-2R) signaling in HTLV-I and interferon-γ (IFN-γ), which is a representative Th1 cytokine, expression in peripheral blood CD4+ T cells from HAM/TSP patients. Patients and Methods: Twelve patients with HAM/TSP were included in the study. After the peripheral blood CD4+ T cells were treated in cultures under the presence of each anti-IL-2Rα, β,and γ blocking antiboby for 48 hours, both HTLV-I p19 antigen and IFN-γ levels in the culture supernatants were measured using ELISA methods. To check the influence on cell proliferation under these culture conditions, the numbers of viable cells were simultaneously determined by MTS assay. Results: Treatment with anti-IL-2Rα blocking antibody, but not anti-IL-2Rβ or anti-IL-2Rγ blocking antibody, suppressed HTLV-I p19 antigen expression levels. In addition, treatment with all types of anti-IL-2R blocking antibodies also suppressed IFN-γ expression levels. All of the types of anti-IL-2R blocking antibodies did not inhibit the proliferation. Conclusion: These results indicate that IL-2/IL-2R signaling is involved in HTLV-I and IFN-γ expression on peripheral blood CD4+ T cells from HAM/TSP patients, suggesting that the interruption of this signaling has therapeutic potential against HAM/TSP in patients with the focus on the down-regulation of Th1 activation based on a high HTLV-I proviral load in the peripheral blood.
Keywords: HAM/TSP / IL-2 / IL-2 receptor / HTLV-I / Th1 / IFN-γ
URI: http://hdl.handle.net/10069/22564
ISSN: 09182918
DOI: 10.2169/internalmedicine.46.6118
Rights: Copyright (c) 2007 (社)日本内科学会
Type: Journal Article
Text Version: publisher
Appears in Collections:Articles in academic journal

Citable URI : http://hdl.handle.net/10069/22564

All items in NAOSITE are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace